Johnson & Johnson's Fiscal Year is From January To December - All Figures are in Percent.
The item "Net-Buyback-Yield" stands at 1.53 percent as of 09/30/2025, the highest value since 12/31/2023.
As of the end of Johnson & Johnson's third quarter, the item "Net Buyback Yield" stands at 1.53 Percent. This represents an increase of 0.22 percentage points compared to it's value at the end of it's second quarter .
Regarding the One-Year-Change of the series, the current value constitutes an increase of 0.8733 percentage points compared to the value the year prior.
The 1 year change in percentage points is 0.8733.
The 3 year change in percentage points is -0.0627.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Net Buyback Yield | 905,699,262,464.00 |
![]() | AbbVie Inc - Net Buyback Yield | 399,570,305,024.00 |
![]() | Roche Holding AG - Net Buyback Yield | 317,433,206,677.55 |
![]() | AstraZeneca PLC - Net Buyback Yield | 280,205,508,085.11 |
![]() | Novartis AG - Net Buyback Yield | 255,096,620,580.91 |